J.C. Walter Jr. Transplant Center

Medicine & Life Sciences

1. Adenocarcinoma 10%
2. Allografts 65%
3. Animals 8%
4. Antibodies 15%
5. Apoptosis 9%
6. B-Lymphocytes 8%
7. Biopsy 16%
8. Blood Vessels 9%
9. Carcinoma 7%
10. Cardiomyopathies 8%
11. Chronic Kidney Failure 8%
12. Chronic Renal Insufficiency 9%
13. Coronavirus 11%
14. Creatinine 9%
15. Cyclosporine 17%
16. Cytokines 11%
17. Dendritic Cells 8%
18. Drainage 8%
19. Education 8%
20. End Stage Liver Disease 7%
21. Equipment and Supplies 7%
22. Fibrosis 12%
23. Genes 11%
24. Germ Cells 9%
25. Glomerulonephritis 8%
26. Graft Rejection 16%
27. Graft Survival 17%
28. Heart 23%
29. Heart Failure 33%
30. Heart Transplantation 11%
31. Heart-Assist Devices 29%
32. Hemodynamics 9%
33. Hepatitis C 7%
34. Hepatocellular Carcinoma 12%
35. Hyperoxia 9%
36. Idiopathic Pulmonary Fibrosis 7%
37. Immunosuppression 20%
38. Immunosuppressive Agents 13%
39. Incidence 11%
40. Infections 8%
41. Inflammation 10%
42. Insulin 7%
43. Interleukin-2 8%
44. Islets of Langerhans 7%
45. Islets of Langerhans Transplantation 7%
46. Kidney 97%
47. Kidney Transplantation 41%
48. Liver 16%
49. Liver Transplantation 69%
50. Living Donors 32%
51. Lung 32%
52. Lung Injury 10%
53. Lung Transplantation 8%
54. Macrophages 17%
55. Messenger RNA 11%
56. Morbidity 7%
57. Mortality 12%
58. Mycophenolic Acid 7%
59. Neoplasms 24%
60. Oocytes 18%
61. Organ Transplantation 12%
62. Pancreas 27%
63. Pancreas Transplantation 31%
64. Pandemics 8%
65. Pediatrics 8%
66. Phenotype 9%
67. Prostate 8%
68. Prostatic Neoplasms 9%
69. Proteins 13%
70. Psychology Rejection 8%
71. Pulmonary Arterial Hypertension 21%
72. Pulmonary Hypertension 16%
73. Recurrence 8%
74. Registries 10%
75. Regulatory T-Lymphocytes 14%
76. Renal Cell Carcinoma 14%
77. RNA 13%
78. Safety 8%
79. Serum 8%
80. Sirolimus 18%
81. Staining and Labeling 7%
82. Surgeons 10%
83. Survival 18%
84. T-Lymphocytes 41%
85. Tacrolimus 11%
86. Technology 7%
87. tezosentan 7%
88. Therapeutics 24%
89. thymoglobulin 11%
90. Tissue Donors 48%
91. Transplant Recipients 53%
92. Transplantation 32%
93. Transplantation Tolerance 15%
94. Transplants 100%
95. treprostinil 7%
96. Tumor Necrosis Factor-alpha 10%
97. Type 1 Diabetes Mellitus 8%
98. Wounds and Injuries 10%
99. Xenopus 15%
100. Xenopus laevis 12%